Cardiovascular Risk
Showing 1 - 25 of 36
Cardiovascular Risk, Acute Myocardial Infarction (AMI) Trial in India (Ziltivekimab, Placebo)
Not yet recruiting
- Cardiovascular Risk
- Acute Myocardial Infarction (AMI)
- Ziltivekimab
- Placebo
-
New Delhi, Delhi, India
- +12 more
Nov 8, 2023
Inflammation in People With Cardiovascular Disease (POSEIDON)
Not yet recruiting
- Cardiovascular Risk
- +2 more
- No treatment given
- (no location specified)
Nov 3, 2023
Cardiovascular Risk Trial in Petaling Jaya (Plant Omega, Dietary therapy only)
Not yet recruiting
- Cardiovascular Risk
- Plant Omega
- Dietary therapy only
-
Petaling Jaya, Selangor, MalaysiaBeacon Hospital Sdn Bhd
May 21, 2023
Cardiovascular Risk, Depression, Unipolar, Depression, Bipolar Trial in Assen, Groningen (LIVE)
Recruiting
- Cardiovascular Risk
- +2 more
- LIVE
-
Assen, Drenthe, Netherlands
- +1 more
Mar 1, 2023
Cardiovascular Risk, Chronic Kidney Disease, Inflammation Trial in Worldwide (Ziltivekimab, Placebo (ziltivekimab))
Recruiting
- Cardiovascular Risk
- +2 more
- Ziltivekimab
- Placebo (ziltivekimab)
-
Birmingham, Alabama
- +768 more
Dec 23, 2022
Obesity, Cardiovascular Risk Trial in Munich (LOGIC)
Active, not recruiting
- Obesity
- Cardiovascular Risk
- LOGIC
-
Munich, Bavaria, GermanyDepartment of Medicine, Division of Prevention, Rehabilitation a
Oct 26, 2022
Cardiovascular Risk, Cardiovascular Prevention Trial in United States (CV Prevention Choice Tool, Implementation Facilitation
Enrolling by invitation
- Cardiovascular Risk
- Cardiovascular Prevention
- CV Prevention Choice Tool
- Implementation Facilitation Strategies
-
Marietta, Georgia
- +3 more
Sep 3, 2022
Patient Blood Management, Cardiovascular Risk, Major Non-cardiac Surgery Trial in Hangzhou (Iron Sucrose, recombinant human
Not yet recruiting
- Patient Blood Management
- +3 more
- Iron Sucrose, recombinant human erythropoietin
- placebo
-
Hangzhou, Zhejiang, ChinaThe Second Affiliated Hospital of Zhejiang University Medical Co
Aug 11, 2022
Chronic Kidney Disease, Inflammation, Cardiovascular Risk Trial in Ehime (Ziltivekimab, Placebo (ziltivekimab))
Completed
- Chronic Kidney Disease
- +2 more
- Ziltivekimab
- Placebo (ziltivekimab)
-
Ehime, JapanNovo Nordisk Investigational Site
Oct 26, 2021
Cardiovascular Risk Trial in Murcia (Dietary supplement consumption)
Completed
- Cardiovascular Risk
- Dietary supplement consumption
-
Murcia, SpainCatholic University of Murcia
Sep 28, 2020
Cardiovascular Risk Trial in Murcia (dietetics)
Completed
- Cardiovascular Risk
- dietetics
-
Murcia, SpainCatholic University of Murcia
Mar 30, 2020
Resistance Training, Cardiovascular Risk, Low Birth Weight Trial (Muscular Resistance training, Cardiorespiratory training,
Completed
- Resistance Training
- +2 more
- Muscular Resistance training
- +2 more
- (no location specified)
Dec 26, 2018
Cardiovascular Risk Trial in Orlando (Behavioral Intervention)
Completed
- Cardiovascular Risk
- Behavioral Intervention
-
Orlando, FloridaFlorida Hospital
Aug 28, 2018
Insulin Sensitivity, Cardiovascular Risk, Perimenopausal Disorder Trial in Richmond (Ortho Cyclen®)
Completed
- Insulin Sensitivity
- +2 more
- Ortho Cyclen®
-
Richmond, VirginiaVirginia Commonwealth University Medical Center
Jul 10, 2018
Obesity, Cardiovascular Risk Trial in Munich (School children and adolescents as health experts)
Completed
- Obesity
- Cardiovascular Risk
- School children and adolescents as health experts
-
Munich, Bavaria, GermanyDepartment of Medicine, Division of Prevention, Rehabilitation a
Oct 12, 2017
Obesity, Type 2 Diabetes, Cardiovascular Risk Trial in Los Angeles (Nutrition, Strength Training & Nutrition)
Completed
- Obesity
- +3 more
- Nutrition
- Strength Training & Nutrition
-
Los Angeles, CaliforniaVeronica Atkins Lifestyle Intervention Laboratory
Mar 29, 2017
Obesity, Type 2 Diabetes, Cardiovascular Risk Trial in Los Angeles (Nutrition, Strength Training & Nutrition, Circuit Training &
Completed
- Obesity
- +3 more
- Nutrition
- +2 more
-
Los Angeles, CaliforniaVeronica Atkins Lifestyle Intervention Laboratory
Mar 29, 2017
Hypertension, Cardiovascular Risk Trial in Seoul (Pitavastatin, Control)
Completed
- Hypertension
- Cardiovascular Risk
- Pitavastatin
- Control
-
Seoul, Korea, Republic ofAsan Medical Center
Oct 13, 2016
Vascular Assessment in Adult Survivors of Childhood Cancer
Completed
- Cardiovascular Risk
- Pediatric Cancer
-
Memphis, TennesseeSt. Jude Children's Research Hospital
Jul 26, 2016
Cardiovascular Risk Trial (Eating habits, diet and exercise)
Completed
- Cardiovascular Risk
- Eating habits, diet and exercise
- (no location specified)
Jan 7, 2016
Cardiovascular Risk Trial in Stuttgart (Energy Drink, Taurine, Caffeine)
Completed
- Cardiovascular Risk
- Energy Drink, Taurine, Caffeine
-
Stuttgart, Baden-Württemberg, GermanyUniversity of Hohenheim
Feb 4, 2015
Cardiovascular Risk Trial in Pittsburgh (SMART PHR, usual care)
Completed
- Cardiovascular Risk
- SMART PHR
- usual care
-
Pittsburgh, PennsylvaniaUPMC Primary Care practices
May 20, 2014
Concordance Between Patients Perception and Physicians
Completed
- Cardiovascular Risk
-
PARIS Cedex 15, FranceResearch Site
May 19, 2014
Cardiovascular Risk, Cancer Trial in Memphis (lifestyle modification and telephone counseling)
Completed
- Cardiovascular Risk
- Cancer
- lifestyle modification and telephone counseling
-
Memphis, TennesseeSt . Jude Children's Research Hospital
Nov 25, 2013
Hypercholesterolemia, Cardiovascular Risk Trial in Barcelona, Castelldefels (Share decision tool)
Completed
- Hypercholesterolemia
- Cardiovascular Risk
- Share decision tool
-
Barcelona, Spain
- +1 more
Mar 2, 2011